ECSP066291A - Sistemas emulsionantes que contienen derivados de azetidina - Google Patents

Sistemas emulsionantes que contienen derivados de azetidina

Info

Publication number
ECSP066291A
ECSP066291A EC2006006291A ECSP066291A ECSP066291A EC SP066291 A ECSP066291 A EC SP066291A EC 2006006291 A EC2006006291 A EC 2006006291A EC SP066291 A ECSP066291 A EC SP066291A EC SP066291 A ECSP066291 A EC SP066291A
Authority
EC
Ecuador
Prior art keywords
systems containing
azetidine
emulsioning
containing derivatives
azetidine derivatives
Prior art date
Application number
EC2006006291A
Other languages
English (en)
Inventor
Sophie Cote
Valerie Bobineau
Maria-Teresa Peracchia
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of ECSP066291A publication Critical patent/ECSP066291A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Psychiatry (AREA)
  • Hematology (AREA)
  • Psychology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Sistemas emulsionantes que contienen derivados de azetidina. Sistemas emulsionantes que contienen derivados de azetidina. La presente invención se refiere a nuevas formulaciones de derivados de azetidina para administración oral.
EC2006006291A 2003-07-18 2006-01-17 Sistemas emulsionantes que contienen derivados de azetidina ECSP066291A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03291797A EP1498123A1 (en) 2003-07-18 2003-07-18 Emulsifying systems containing azetidine derivatives

Publications (1)

Publication Number Publication Date
ECSP066291A true ECSP066291A (es) 2006-07-28

Family

ID=33462260

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2006006291A ECSP066291A (es) 2003-07-18 2006-01-17 Sistemas emulsionantes que contienen derivados de azetidina

Country Status (31)

Country Link
US (1) US20050037062A1 (es)
EP (2) EP1498123A1 (es)
JP (1) JP2009513559A (es)
KR (1) KR20060040690A (es)
CN (1) CN1822830A (es)
AR (1) AR045912A1 (es)
AU (1) AU2004262497A1 (es)
BR (1) BRPI0412239A (es)
CA (1) CA2532668A1 (es)
CR (1) CR8178A (es)
EC (1) ECSP066291A (es)
GT (1) GT200400134A (es)
HR (1) HRP20060021A2 (es)
IL (1) IL173113A0 (es)
MA (1) MA27921A1 (es)
MX (1) MXPA06000478A (es)
MY (1) MY142076A (es)
NO (1) NO20060510L (es)
NZ (1) NZ544707A (es)
OA (1) OA13190A (es)
PA (1) PA8606601A1 (es)
PE (1) PE20050699A1 (es)
RS (1) RS20050971A (es)
RU (1) RU2348615C2 (es)
SG (1) SG144140A1 (es)
TN (1) TNSN06012A1 (es)
TW (1) TW200522946A (es)
UA (1) UA82539C2 (es)
UY (1) UY28422A1 (es)
WO (1) WO2005013972A1 (es)
ZA (1) ZA200600489B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1498122A1 (en) * 2003-07-18 2005-01-19 Aventis Pharma S.A. Semi-solid systems containing azetidine derivatives
EP1959926A1 (en) * 2005-10-25 2008-08-27 Abbott Laboratories Formulation comprising a drug of low water solubility and method of use thereof
EP2068723A4 (en) * 2006-09-29 2015-04-01 Pluromed Inc METHOD FOR PREVENTING STONE AND FRAGMENT RETROPULSION DURING A LITHOTRYPSY
ES2551125T3 (es) * 2007-08-21 2015-11-16 Basilea Pharmaceutica Ag Composición antifúngica
FR2923719B1 (fr) * 2007-11-15 2009-11-20 Sanofi Aventis Compositions pharmaceutiques a base de derives d'azetidine
IT1394400B1 (it) * 2009-02-25 2012-06-15 Neuroscienze Pharmaness S C Ar L Composizioni farmaceutiche
CA2982162C (en) * 2015-04-10 2023-10-10 Bioresponse, L.L.C. Self-emulsifying formulations of dim-related indoles
CN106551902B (zh) * 2015-09-17 2020-07-03 阿赖耶识（上海）生物技术有限公司 一种高稳定的非囊泡型纳米颗粒及其在治疗微生物感染中的应用
JOP20190260A1 (ar) 2017-05-02 2019-10-31 Merck Sharp & Dohme صيغ ثابتة لأجسام مضادة لمستقبل الموت المبرمج 1 (pd-1) وطرق استخدامها
WO2018204374A1 (en) 2017-05-02 2018-11-08 Merck Sharp & Dohme Corp. Formulations of anti-lag3 antibodies and co-formulations of anti-lag3 antibodies and anti-pd-1 antibodies
US20240277615A1 (en) * 2021-06-11 2024-08-22 Universidade Da Beira Interior Self-emulsifying composition, production methods and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9405304D0 (en) * 1994-03-16 1994-04-27 Scherer Ltd R P Delivery systems for hydrophobic drugs
JP2740153B2 (ja) * 1995-03-07 1998-04-15 エフ・ホフマン−ラ ロシユ アーゲー 混合ミセル
GB9600235D0 (en) * 1996-01-05 1996-03-06 Pfizer Ltd Therapeutic agents
US6355631B1 (en) * 2000-03-03 2002-03-12 Aventis Pharma S.A. Pharmaceutical compositions containing azetidine derivatives, novel azetidine derivatives and their preparation
FR2814678B1 (fr) * 2000-10-04 2002-12-20 Aventis Pharma Sa Association d'un antagoniste du recepteur cb1 et de sibutramine, les compositions pharmaceutiques les contenant et leur utilisation pour la traitement de l'obesite
FR2829027A1 (fr) * 2001-08-29 2003-03-07 Aventis Pharma Sa Association avec un antagoniste du recepteur cb1, les compositions pharmaceutiques les contenant et leur utilisation pour le traitement de la maladie de parkinson
FR2833842B1 (fr) * 2001-12-21 2004-02-13 Aventis Pharma Sa Compositions pharmaceutiques a base de derives d'azetidine

Also Published As

Publication number Publication date
MXPA06000478A (es) 2006-04-05
PA8606601A1 (es) 2005-03-03
KR20060040690A (ko) 2006-05-10
UA82539C2 (en) 2008-04-25
IL173113A0 (en) 2006-06-11
AU2004262497A2 (en) 2005-02-17
RS20050971A (sr) 2008-06-05
SG144140A1 (en) 2008-07-29
NZ544707A (en) 2009-01-31
MY142076A (en) 2010-08-30
GT200400134A (es) 2005-02-22
CN1822830A (zh) 2006-08-23
ZA200600489B (en) 2007-04-25
TNSN06012A1 (en) 2007-10-03
US20050037062A1 (en) 2005-02-17
EP1498123A1 (en) 2005-01-19
WO2005013972A1 (en) 2005-02-17
RU2006105000A (ru) 2006-07-10
MA27921A1 (fr) 2006-06-01
UY28422A1 (es) 2005-02-28
EP1648441A1 (en) 2006-04-26
AR045912A1 (es) 2005-11-16
OA13190A (en) 2006-12-13
JP2009513559A (ja) 2009-04-02
HRP20060021A2 (en) 2006-02-28
AU2004262497A1 (en) 2005-02-17
BRPI0412239A (pt) 2006-09-12
CR8178A (es) 2007-12-04
PE20050699A1 (es) 2005-09-15
CA2532668A1 (en) 2005-02-17
TW200522946A (en) 2005-07-16
NO20060510L (no) 2006-01-31
RU2348615C2 (ru) 2009-03-10

Similar Documents

Publication Publication Date Title
HN2003000408A (es) Nuevos derivados de fluoroglicosidos heterociclicos, medicamentos que contienen estos compuestos, y el uso de los mismos.
CO5590918A2 (es) Formulaciones
CY1111470T1 (el) Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α
PA8595901A1 (es) "n-arilheterociclos sustituidos, procedimientos para su preparacion, y su empleo como medicamentos
UY28215A1 (es) Quinazolinas utiles como moduladores de canales iónicos
HN2002000300A (es) Nuevos derivados de piperazina
BRPI0408895A (pt) formulações de cladribina para administração oral e transmucosal aperfeiçoada
UY27852A1 (es) Difenilazatidinonas cationicamente sustituidas, procedimiento para su preparacion, medicamentos que comprenden estos compuestos y su uso.
ECSP066291A (es) Sistemas emulsionantes que contienen derivados de azetidina
BRPI0408848A (pt) formulações orais de cladribine
MXPA06000636A (es) Formulaciones semi-solidas para la administracion oral de taxoides.
NO20064808L (no) Orale matrixformuleringer med licarbazepin
UY28421A1 (es) Sistemas semi-sólidos que contienen derivados de azetidina
UY29817A1 (es) Nuevos compuestos de azetidina, composiciones farmacéuticas que los contienen, procesos de preparación y uso terapéutico de los mismos.
HN2002000082A (es) Composiciones que contienen imidazotriazinona para administracion nasal
UY27824A1 (es) Nueva formulación para la administración parenteral de crobenetina.
HN2002000084A (es) Fenil - heterociclil - eteres
HN2002000049A (es) Nuevos compuestos antiinflamatorios de triazolopiridinas
HN2002000331A (es) Composiciones farmaceuticas de 5,7,14-triazatetra-ciclo (10.3.1.02,11.04,9)-hexadeca-2(11) 3,5,7,9-pentaeno
UY27823A1 (es) Nueva formulación para la administración parenteral de un bloqueante del canal del na